Skip to content

A New Paradigm in eClinical Technology

1-888-488-0312 or

Menu

Home
eClinical Software
Services
Experience
Partners
- Contract Research Organizations
Contact Us
- Careers
- Newsletter Registration
News / Blog
On Air!

Menu

×

Home
eClinical Software
Services
Experience
Partners
- Contract Research Organizations
Contact Us
- Careers
- Newsletter Registration
News / Blog
On Air!

TrialStat Corporate Overview 23-09-2019

By Chris Kata | September 24, 2019

Latest News

Cellevolve Bio Submits Investigational New Drug (IND) Application for Global Phase 2, Placebo-controlled Study of CE-VST01-JC for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) October 4, 2022
Meet with Christopher Kata during the “24th Annual SoCalBio Conference” October 6th to 7th! October 4, 2022
Sonnet BioTherapeutics Announces Progress in Two Phase 1 Dose-Escalation Trials of SON-1010 October 4, 2022
Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz Munich at the 9th Immunotherapy of Cancer Conference October 4, 2022
The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form of ALS October 3, 2022

Archives

Categories

TrialStat Solutions Inc.

Head Office:

16751, TransCanada Hwy
Kirkland (Montreal), QC
Canada H9H 4J4

Telephone: 1-888-488-0312
Technical Support: 1-866-416-7828 ext. 2
Fax: 1-613-274-3674

Reach Us By Email

Support: [email protected]
Sales: [email protected]

Meet Us Virtually

We are hosting a series of webinars over the coming months and would love to have you attend.

Upcoming Meetings

Additional Information

Privacy Policy
Press Releases

© 2022 TrialStat Solutions Inc. All Rights Reserved.